Psyence Biomedical Ltd.
PBM
$3.48
-$0.08-2.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.94M | -5.44M | -3.94M | -1.46M | 1.01M |
| Total Depreciation and Amortization | 5.20K | 5.10K | 5.00K | 4.60K | 4.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.20K | 29.00K | 53.80K | -2.16M | -4.36M |
| Change in Net Operating Assets | -1.22M | -790.60K | -365.00K | -375.60K | -386.20K |
| Cash from Operations | -8.14M | -6.20M | -4.25M | -3.99M | -3.73M |
| Capital Expenditure | -200.00 | -1.90K | -3.60K | -6.70K | -9.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.51M | -4.26M | -4.02M | -2.01M | -6.40K |
| Cash from Investing | -4.51M | -4.27M | -4.02M | -2.02M | -16.20K |
| Total Debt Issued | -- | 0.00 | 0.00 | 500.00K | 1.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 871.00K | 1.74M | 1.74M | 1.74M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 13.96M | 12.85M | 11.74M | 9.08M | 6.41M |
| Cash from Financing | 13.96M | 13.73M | 13.49M | 11.32M | 9.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.31M | 3.26M | 5.22M | 5.31M | 5.40M |